BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37986225)

  • 1. Epigenetic regulation of asymmetric cell division by the LIBR-BRD4 axis.
    Chen HF; Chang CT; Hsu KW; Peng PH; Lai JC; Hung MC; Wu KJ
    Nucleic Acids Res; 2024 Jan; 52(1):154-165. PubMed ID: 37986225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
    Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of bromodomain protein 4 in regulation of stem cell identity.
    Dey A; Uppal S; Giri J; Misra HS
    Stem Cells; 2021 Dec; 39(12):1615-1624. PubMed ID: 34520583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A deregulated m
    Lu X; Peng L; Ding J; Li Y; Li Q; Rao M; Shu T; He X; Liu C; Ye J; Liu W; You H
    Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2304534120. PubMed ID: 37782793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRD4-binding enhancer promotes CRC progression by interacting with YY1 to activate the Wnt pathway through upregulation of TCF7L2.
    Duan B; Zhou X; Zhang X; Qiu F; Zhang S; Chen Y; Yang J; Wang J; Tan W
    Biochem Pharmacol; 2023 Dec; 218():115877. PubMed ID: 37879498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA
    Pistoni M; Rossi T; Donati B; Torricelli F; Polano M; Ciarrocchi A
    Mol Cancer Res; 2021 May; 19(5):799-811. PubMed ID: 33547232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA MALAT1 Promotes Laryngocarcinoma Development by Targeting miR-708-5p/BRD4 Axis to Regulate YAP1-Mediated Epithelial-Mesenchymal Transition.
    Wu X; Tan Y; Tang X
    Biomed Res Int; 2022; 2022():8093949. PubMed ID: 35601153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.
    Chen Y; Ying Y; Ma W; Ma H; Shi L; Gao X; Jia M; Li M; Song X; Kong W; Chen W; Zheng X; Muluh TA; Wang X; Wang M; Shu XS
    Cancer Res; 2024 Apr; 84(8):1237-1251. PubMed ID: 38241700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma.
    Markman RL; Webber LP; Nascimento Filho CHV; Reis LA; Vargas PA; Lopes MA; Zanella V; Martins MD; Squarize CH; Castilho RM
    Cell Oncol (Dordr); 2019 Apr; 42(2):143-155. PubMed ID: 30539410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct layers of BRD4-PTEFb reveal bromodomain-independent function in transcriptional regulation.
    Zheng B; Gold S; Iwanaszko M; Howard BC; Wang L; Shilatifard A
    Mol Cell; 2023 Aug; 83(16):2896-2910.e4. PubMed ID: 37442129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRD4 in physiology and pathology: ''BET'' on its partners.
    Liang Y; Tian J; Wu T
    Bioessays; 2021 Dec; 43(12):e2100180. PubMed ID: 34697817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The P53-P21-RB1 pathway promotes BRD4 degradation in liver cancer through USP1.
    Li N; Zhang E; Li Z; Lv S; Zhao X; Ke Q; Zou Q; Li W; Wang Y; Guo H; Song T; Sun L
    J Biol Chem; 2024 Mar; 300(3):105707. PubMed ID: 38309505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological stage-associated non-coding RNA long intergenic non-protein coding RNA 1234 (LINC01234) participation in cell cycle regulation in adrenocortical carcinoma through bromodomain-containing protein 4 (BRD4) expression mediation via sponging microRNA (miR)-140-3p.
    Zhu DD; Yu XB; Jiang W; Zhu Y
    Bioengineered; 2022 May; 13(5):13607-13621. PubMed ID: 35765893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging roles of and therapeutic strategies targeting BRD4 in cancer.
    White ME; Fenger JM; Carson WE
    Cell Immunol; 2019 Mar; 337():48-53. PubMed ID: 30832981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRD4 Promotes Gastric Cancer Progression and Metastasis through Acetylation-Dependent Stabilization of Snail.
    Qin ZY; Wang T; Su S; Shen LT; Zhu GX; Liu Q; Zhang L; Liu KW; Zhang Y; Zhou ZH; Zhang XN; Wen LZ; Yao YL; Sun WJ; Guo Y; Liu KJ; Liu L; Wang XW; Wei YL; Wang J; Xiao HL; Liu P; Bian XW; Chen DF; Wang B
    Cancer Res; 2019 Oct; 79(19):4869-4881. PubMed ID: 31311807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of novel ligand targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery: complete pharmacophore approach.
    Shanmugam V; Muthukrishnan S
    J Biomol Struct Dyn; 2023; 41(23):14524-14539. PubMed ID: 36841551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.
    Jung M; Philpott M; Müller S; Schulze J; Badock V; Eberspächer U; Moosmayer D; Bader B; Schmees N; Fernández-Montalván A; Haendler B
    J Biol Chem; 2014 Mar; 289(13):9304-19. PubMed ID: 24497639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review).
    Yongprayoon V; Wattanakul N; Khomate W; Apithanangsiri N; Kasitipradit T; Nantajit D; Tavassoli M
    Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38606512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAM222A, Part of the BET-Regulated Basal Endothelial Transcriptome, Is a Novel Determinant of Endothelial Biology and Angiogenesis-Brief Report.
    Tzani A; Haemmig S; Cheng HS; Pérez-Cremades D; Heuschkel MA; Jamaiyar A; Singh SA; Aikawa M; Yu PB; Wang T; Sun Y; Feinberg MW; Plutzky J
    Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):143-155. PubMed ID: 37942611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone H4 acetylation and the epigenetic reader Brd4 are critical regulators of pluripotency in embryonic stem cells.
    Gonzales-Cope M; Sidoli S; Bhanu NV; Won KJ; Garcia BA
    BMC Genomics; 2016 Feb; 17():95. PubMed ID: 26847871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.